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Summary.-Thymidine incorporation in vitro by remission lymphocytes from a
total of 6 patients with acute myeloid leukaemia (AML) was measured following
stimulation by autochthonous and allogeneic AML blasts and cell lines. The early
peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent
with the concept of a population of lymphocytes pre-immunized to antigens carried
by the blasts. Although stimulation in one patient was increased in the presence
of more stimulating (S) blasts than responding (R) lymphocytes, positive responses
in other tests were obtained at an S: R ratio of 1 :1-5. When different methods
of treatment of the stimulating autochthonous blasts were compared with untreated
cells, mitomycin C gave the highest stimulation indices in 2 out of 3 tests. Tissue
culture medium in which autochthonous blasts had been incubated for 3-5 days
failed to stimulate either remission lymphocytes alone, or combined cultures of
lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic
factors released from autochthonous blasts are not responsible for lymphocyte
stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-
HC1 (pH 3-0) to remove putative " blocking " factors failed to increase the stimulatory
capacity of the leukaemic blasts.
THE SEARCH for antigens characteristic
of neoplastic cells which may have
diagnostic or therapeutic significance has
been one of the primary aims of tumour
immunology. The evidence of such anti-
gens specific to human leukaemic cells
is based largely on observations that DNA
synthesis by lymphocytes from patients in
remission is stimulated by autochthonous
acute-phase leukaemic blasts (Fridman
and Kourilsky, 1969; Viza et al., 1969;
Powles et al., 1971) though the existence
of such antigens on lymphoblastic leuk-
aemic cells using this test has been
disputed (Schweitzer, Melief and Eijs-
voogel, 1973).
The clinical value of this test appears
to be as an indicator of prognosis and
minimal residual disease. Thus patients
whose lymphocytes are strongly stimu-
lated by autochthonous blasts are more
likely to enter and remain in remission
for more than one year, than those
whose lymphocytes are weakly stimulated
(Gutterman et al., 1974).
In view of the potential clinical
importance ofthe lymphocyte stimulation
test in predicting remission length and
residual disease, its possible use in moni-
toring the effects of immunotherapy
(Powles et al., 1971; Gutterman et al.,
1973a) and the induction of cell-mediated
cytotoxicity (Taylor, Harris and Freeman,
1976), further clarification of its nature
is long overdue. This study investigates
variables determining the response to
autochthonous AML blasts by lympho-
cytes from AML patients in remission
who are receiving allogeneic AML blasts
as part of their immunotherapy.G. M. TAYLOR, C. B. FREEMAN AND R. HARRIS
MATERIALS AND METHODS
Patients: remission induction.-The 6
patients (JC, MI, AH, HH, SW and BH)
whose responses to autochthonous leukaemic
blasts and allogeneic cells were measured
were all treated with induction chemotherapy
consisting of cytosine arabinoside (Ara-C,
2-0 mg/kg body wt) administered i.v. in
5-day courses with gaps of 5 days, and
daunorubicin (1.5 mg/kg body wt) in 6
courses coinciding with the first day of
Ara-C. When the patients were in full re-
mission (<50 blasts in the bone marrow)
they received a single course of Ara-C/dauno-
rubicin as above, and commenced immuno-
therapy one week later.
Maintenance treatment.-The patients
were then randomized to receive weekly
immunotherapy according to one of two
protocols. Both groups received weekly in-
jections of 109 viable, allogeneic AML
blasts pre-irradiated at 104 rad (137Cs source),
distributed between three limbs, and 109
live BCG organisms (Glaxo Laboratories,
Greenford) delivered into the fourth limb
by multiple puncture with a Heaf gun
(Freeman et al., 1973). In addition, one
of the groups of patients received monthly
maintenance chemotherapy consisting of
5-day courses of Ara-C (2-0 mg/kg orally)
and daunorubicin (I-5 mg/kg), the latter at
2-monthly intervals.
Leukaemic blasts.-Leukaemic blasts were
obtained from the peripheral blood of the
patients prior to induction chemotherapy,
either by aspiration of venous blood into
heparinized bottles or, where clinically in-
dicated, by leucophoresis by means of an
NCI-IBM continuous-flow cell separator.
In the case of the leucophoresis patients,
plasma and erythrocytes were returned to
the patient, whilst the buffy coat was
collected into a sterile blood bottle. Where
whole venous blood was collected, erythro-
cytes were sedimented at 37°C with Dextran
110 (Fisons, Loughborough).
Leucocytes obtained by leucophoresis
and dextran sedimentation were diluted
with antibiotic-free TC199, buffered with
sodium bicarbonate or HEPES (Gibco Bio-
Cult, Glasgow) containing dimethyl sulph-
oxide (DMSO) at 4°C to give a final cell sus-
pension containing 10% autologous plasma,
10% DMSO and 80% TC199. The cell
suspensions were dispensed in 2 ml aliquots
at concentrations of 107- 2 x 107/ml into
sterile 5 ml glass ampoules, which were
then sealed and cooled to 4°C. The ampoules
were frozen at a rate of -1°C/min to - 150°C
in a programmed freezer (R201, G. V.
Planer Ltd) and then stored at -120°C
in the vapour phase ofa liquid N2 refrigerator
(LR-320, Union Carbide, Darlington).
Preparation of responding lymphocytes.-
Venous blood obtained from remission AML
patients was anticoagulated with heparin
(10 iu/ml) or by defibrination with sterile
glass beads. A lymphocyte-enriched leuco-
cyte population was obtained by layering
the whole blood-in some cases diluted
1: 1 with sterile Ringer solution (Baxter
Laboratories, Thetford, Norfolk)-over 5 ml
(whole blood) or 3 ml (diluted blood) of a
mixture of 9% Ficoll (Pharmacia, Uppsala,
Sweden) and 33% Triosil (Nyegaard, Oslo,
Norway) (24 parts: 10 parts) in straight-sided
flat-bottomed glass tubes (100 x 14 mm)
followed by centrifugation at 4°C for 40 min
at 400 g (B6yum, 1968). The interface of
the plasma and Ficoll/Triosil-containing lym-
phocyte-enriched leucocytes was gently re-
moved with glass pipettes, placed in glass
centrifuge tubes and washed twice by
centrifugation in TC199/HEPES containing
10% foetal calf serum (FCS) (Welleome
Laboratories, Kent). The cells were ad-
justed to 1-5 x 106/ml by counting in
trypan blue.
Preparation of stimulating cells.-The
autochthonous and allogeneic cells used as
stimulating cells were obtained from storage
in liquid N2, and were thawed rapidly by
agitation of the ampoules in a water bath
at 37°C, after which the cells were washed
once in cold TC199/HEPES containing
10% FCS.
Allogeneic cell lines used as stimulating
cells in some ofthe experiments were derived
originally from Burkitt's lymphomata and
designated Raji or Jijoye (see Klein, 1973).
They were maintained in suspension culture
in Falcon 3013 culture flasks (Falcon Plastics,
Oxnard, California) in suspension Eagles
Medium (S-MEM, Gibco Bio-Cult, Glasgow)
containing 10% FCS and sub-cultured
once or twice weekly.
All stimulating cells were treated with
mitomycin C (25 ,ug/107 cells) unless otherwise
stated, for 30 min at 37°C to inhibit DNA
synthesis by the stimulating cells whilst in
mixed culture. The cells were then washed
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3 x in TC199/HEPES/FCS and adjusted to
106 cells/ml unless otherwise stated.
Mixed cell cultures.-Mixed cultures (1 ml)
consisting of equal volumes of patients'
responding (R) leucocytes (1.5 x 106/ml) and
stimulating (S) cells (autochthonous or
allogeneic AML blasts, or cell-lines,
1.0 x 106/ml) giving an R: S ratio of
1-5: 1, were initiated in screw-topped glass
tissue culture tubes (120 x 16 mm, Flow
Laboratories, Scotland). Control cultures
consisted of responding leucocytes and
stimulating cells cultured in separate tubes,
but in the same total culture volume (1 ml)
as the mixed cultures. Three cultures were
set up for each test combination and in-
cubated for 4-6 days unless otherwise stated,
after which they were labelled with 2 ,uC
of methyl-3H-thymidine (3H-TdR sp. act. 2
Ci/mmol, TRA 310, Radiochemical Centre,
Amersham) for 18 h at 37°C. The cultures
were then cooled to 4°C, diluted with 10 vol.
of saline, agitated vigorously in a vortex
mixer, and washed through glass fibre
filters (Whatman GF/C, 2-5 cm diam.) under
negative pressure. The filters were then
washed with equal volumes (10 ml) of 50o
trichloracetic acid, and absolute methanol,
transferred to glass scintillation vials, and
dried at 160°C for 2 h. The vials were
cooled to room temperature, and the filters
flooded with 10 ml scintillation fluid (toluene,
1 litre; PPO, 6 g; POPOP, 10 mg, Koch-
Light Laboratories, Bucks), then cooled to
4°C prior to counting on a Nuclear Chicago
Unilux II liquid scintillation counter. The
results of mixed and control cultures are
expressed as mean ct/min 3H-TdR incorpora-
tion ±1 s.d. of three cultures. Where
appropriate, Student's t tests were used to
calculate statistical significance.
RESULTS
Time course ofthe response to autochthonous
blasts and allogeneic cells
The response of 3 remission AML
patients to their own acute-phase leuk-
aemic blasts, to allogeneic immunotherapy
blasts or to allogeneic Raji cells over
a period of 1-7 days is depicted in Fig.
1(a-c). In view of the unexpectedly
low level of stimulation by allogeneic
AML blasts in these experiments (and
in others to be published) we included
Raji cells as a positive control in one
experiment (Fig. la). The curves show
the 3H-TdR incorporation by lympho-
cytes mixed with mitomycin C-treated
stimulating cells and in separate control
cultures (see Methods). The stimulation
indices, calculated by dividing the 3H-
TdR incorporation in the mixed by the
control cultures, are shown for each
combination with an indication of the
significance of the mixed culture response.
In 2 of the 3 patients (AH and JC)
significant lymphocyte stimulation was
elicited by autochthonous blasts (Fig. la,
b), whilst no stimulation occurred in
the third patient (MI, Fig. lc), whose
lymphocytes in the mixed culture in-
corporated significantly less 3H-TdR than
in the control.
Two of the patients (AH and MI)
were receiving monthly maintenance che-
motherapy in addition to weekly immuno-
therapy (I + C), though this probably
does not account for the lack of response
by MI to autochthonous blasts, since
(1) the patient tested subsequently (un-
published) failed to respond to her
autochthonous blasts, and (2) the patient
responded to allogeneic imimunotherapy
blasts (Fig. lc). The peak response to
the autochthonous blasts in patients JC
and AH occurred 2 to 3 days after the
initiation of the culture (48 72 h). By
the seventh day of culture, autochthonous
blast-stimulated lymphocytes from AH
(Fig. la) incorporated significantly less
3H-TdR than in the control cultures,
and there was a steady decline in 3H-TdR
incorporation by the autochthonous blast-
stimulated lymphocytes from patient JC
(Fig. lb), a patient receiving immuno-
therapy only as maintenance treatment.
All patients had a positive response
to allogeneic cells. In the case of patient
AH (Fig. la) the autochthonous response
was compared with the response to
allogeneic Raji cells, the latter having a
much greater stimulatory effect on re-
mission lymphocytes than autochthonous
blasts. The control Raji cultures in-
corporated significant amounts of3H-TdR,
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FIG. l(a-c). Time course of lymphocyte re-
sponse in mixed culture with autochthonous
AML blasts (@), allogeneic Raji cells (Fig.
la) or allogeneic immunotherapy AML
blasts (Fig. lb, c) (*). Controls consist
of lymphocytes and autochthonous (0) or
allogeneic cells (0O) cultured separately. Fig.
la, patient AH; Fig. lb, patient JC; Fig.
Ic, patient MI. Significant stimulation
(>1 0 O) or inhibition (<1 0 O) in mixed cul-
ture, compared with control, indicated by
stimulation indices (SI) in box below fig.
*** = P < 0-001, P < 0.01,* p
<0 05.
particularly 24 h after initiation of the
cultures, which suggested that significant
numbers ofstimulatory cells were dividing
in spite of mitomycin C treatment,
though the level of 3H-TdR incorporation
fell steadily over the 7-day culture
period. Nevertheless the lymphocytes in
the mixed lymphocyte-Raji culture incor-
porated three times as much 3H-TdR
as the controls on the third dav of culture.
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resulting in a higher stimulation index
4 than that obtained with autochthonous
blast-stimulated lymphocytes. The re-
1.59.** sponse to allogeneic blasts by JC (Fig.
1.49'*' lb) closely resembled the response to
autochthonous blasts in time-course kine-
tics and in the level of stimulation ob-
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tained, though this does not necessarily
imply that the stimulatory antigens are
the same. The response by MI (Fig. 1c)
to allogeneic blasts in mixed culture was
significantly inhibited on Day 2 of culture
compared with the control, but was
followed by a recovery by Day 4 to give a
significant response.
Dose response to autochthonous AML
blasts
The dose dependency of the response
to autochthonous blasts was studied in
2 patients, tested at a different time
from the tests carried out in the previous
section. One patient (JC) had been found
to be a regularly positive responder,
whilst the other (MI) was a negative
responder in tests not shown. The re-
sponse of one of the patients (JC (I),
Fig. 2a) increased as the number of
stimulating blasts increased, whilst the
response ofthe other patient (MI (I + C),
Fig. 2b) was unaffected by an increase
in the number of stimulating blasts, and
was in fact significantly inhibited by
autochthonous blasts. In the test on
lymphocytes from patient JC (Fig. 2a)
we observed that an S : R ratio of
0-6: 1 was non-stimulatory, though at
a ratio of 2-6: 1 autochthonous blasts
induced significant stimulation. How-
ever, in view of the fact that other tests
using the S: R ratio 0-6: 1 (or 1: 1.5
as described in the Methods) were found
to give stimulation, though possibly of
a lower magnitude, we used this ratio
routinely to preserve our store of leuk-
aemic blasts.
Effect of preparation on the stimulatory
capacity of AML blasts
For routine tests, lymphocytes were
stimulated with mitomycin C-treated auto-
chthonous blasts. This method of cell
preparation was more specifically examin-
ed in comparison with other methods in
further tests at a later stage of remission
in patient JC, and in 2 other patients
(HH and BH). Autochthonous blasts
8
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FIG. 2(a, b).-Dose-dependencyoflymphocyte
response in mixed culture with auto-
chthonous AML blasts (0) compared with
controls (0), (a) in patient JC and (b) in
patient MI; for further details see Fig. 1.
were treated with mitomycin C, x-irradi-
ated at 2 x 103rad, heated to 56°C
for 10min, or were left untreated. All
cell preparations were washed once fol-
lowing treatment, and adjusted to the
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usual stimulating cell concentration
(1.0 x 106/ml). Apart from the heated
cells which were 100% dead, the viability
of the other cell preparations exceeded
90%. The results in Table I show that
2 of the 3 patients tested (HH (I) and
JC (I)) responded positively to one or
more of the cell preparations, whilst the
third patient (BH (I)) failed to respond
to any of his autochthonous blasts,
irrespective of treatment. The two posi-
tive responders (HH and JC) responded to
mitomycin C-treated autochthonous blasts
and, whereas the responses of patient JC
to cells prepared by the other 3 methods,
including heat killing, were positive, the
response in patient HH to untreated
cells was not significantly positive and
was in fact significantly inhibited by
heated and x-irradiated cells.
Effect of blast-cell-conditioned medium
One possible explanation for the stimd-
latory effect of autochthonous AML
blasts on remission lymphocytes could
be that the blasts release soluble mitogenic
factors which lack antigenic specificity.
Such factors would not be detected in
the control cultures used here since
lymphocytes were culturedseparatelyfrom
blasts. The possibility that non-specific
blast cell mitogenic factors are able to
stimulate remission lymphocytes was test-
ed in the following experiments. Autoch-
thonous AML blasts were pre-incubated
in culture medium for 3-5 days at con-
centrations of 0-5-1-0 x 106 cells/ml. The
cells were then centrifuged and the
supernatant medium passed through 0.22
,um Millipore filters to produce blast-cell-
conditioned medium. Mixed and control
cultures were set up as previously de-
scribed, in both media. The results of
experiments with remission lymphocytes
from 3 patients (HH, JC and SW, all
receiving I) obtained at further stages
of treatment than in the previous experi-
ments are shown in Table II. There
was no significant effect of conditioned
medium on lymphocytes incubated alone,
whilst there was a significant reduction
in the response to autochthonous blasts
in one patient (HH) and to allogeneic
AML blasts in 2 of the 3 patients (HH
and JC). In one test (JC) there was a
significant increase in 3H-TdR incorpora-
tion in Jijoye cells cultured alone in the
presence of conditioned medium, whilst
the mnixed culture ofthe patient's lympho-
cytes (JC) and Jijoye cells responded
less well in the conditioned medium
than in normal medium. There was
thus no evidence from these experiments
that blast-cell-conditioned medium had
a mitogenic effect on remission lympho-
cytes, and there was some suggestion of
an inhibitory effect.
Effect of cell treatment
The surface of cancer cells may be
modified by serum factors which may
have the effect of masking neo-antigens.
In this study we considered that such
factors might be the result of a humoral
response, and that complexes of antigen
and antibody could be present on the
cell surface. Such complexes may be
removed either by incubating leukaemic
cells in culture medium for a number
of days or elution with glycine-HCl (pH
3.0) to cleave antigen from antibody.
The effect of treating autochthonous
and allogeneic blasts and Raji cells with
glycine-HCl on the response of lympho-
cytes from two patients is shown in
Table III. Autochthonous and allogeneic
blasts and Raji cells were treated for
5-10 min at 4TC with 1 ml of glycine per
107 cells, washed immediately 3-4 x
with 10 vol. of TC199/HEPES containing
10% FCS. The cells were adjusted to
1.0 x 106/ml (viability >90%) and cul-
tured with remission lymphocytes, in
parallel with mixed cultures of remission
lymphocytes and untreated blasts. The
results depicted in Table III clearly show
no significant increase in the response
either to autochthonous or to allogeneic
blasts or to Raji cells. Indeed, treat-
ment of the autochthonous blasts from
JC and the Raji cells reduced their
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TABLE III.-
Culture
Lymphocytes +aut.
blasts* (control)
Lymphocytes x aut.
blasts
Lymphocytes +allo.
blastst (control)
Lymphocytes x allo.
blasts
Lymphocytes+allo.
cell: line (control)
Lymphocytes x allo.
cell line
-Effect of Glycine Treatment of AML Blasts and Allogeneic Cells
on Lymphocyte Response
Treatment
of
stimulating
cells
None
Glycine
None
Glycine
None
Glycine
None
Glycine
None
Glycine
None
Glycine
3H-TdR Incorporation by lymphocytes from:
Patient JC
ct/min ±sd P SI§
4476±544 NS
4458± 602
8372±461 <0-001 1-87***
3577±774 0.78*
5239± 1181 NS
4950±557
4318± 784 NS 0 82
4026±24 0-81
5558±559 <0-01
4408± 769
63001 ±11261 <0-001 11-33***
3221±396 0 73
Patient HH
ct/min 4-sd P
3221 ±524 <0-01
4745±977
1016±369 NS
3612±1221
5537±1208 NS
5810± 1470
2377±801
4230± 182
ND
14845± 2682
2109± 1184
<0 005
* Autochthonous AML blasts.
t Allogeneic AML blasts.
+ Allogeneic Raji cells.
§ Stimulation index test cells in mixed culture Significance as in Table I
test cells in control culture
TABLE IV. Stimulation Capacity by Autochthonous Cultured Myeloblasts
3H-TdR by lymphocytes from:
Culture
Lymphocytes+auto. blasts
(control)
Lymphocytes x auto. blasts
Lymphocytes +auto. cultured blasts
(control)
Lymphocytes x auto. cultured blasts
Patient HH
ct/min±sd SI Pt
1510±378
10312± 1101
--l
10312i 1101
2721 ± 239
3827± 1064
4- 10***
1 -40
Patient SW
ct/min ±sd SI Pt
822±106
1 -99***
<0 -001 1639±+469
816± 61
5068± 132
6-21***
t Student's t test comparing ct/min in lymphocytes cultured with normal and cultured blasts.
Stimulation index and significance as in Table I.
immunogenicity in mixed culture with
lymphocytes.
Autochthonous blasts from patients
HH and SW were cultured alone for
3 days, washed, and mixed with remission
lymphocytes. The results shown in Table
IV differed markedly since patient HH
showed a decrease in response to cultured
blasts whilst patient SW showed a
marked increase. It is significant that
patient HH responded regularly in re-
peated tests to unmodified blasts, whilst
patient SW did not (to be published).
DISCUSSION
Lymphocytes from patients with acute
lymphoblastic and myeloblastic leukaemia
(ALL and AML) in remission are known
to respond in some cases to leukaemic
cells from the acute phase of the disease
with an increase in the incorporation
of 3H-TdR (Fridman and Kourilsky,
1969; Viza et al., 1969; Powles et al.,
1971). Although similar lymphocyte re-
sponses have been observed to cells
from solid tumours (Ambus et al., 1974;
Vanky et al., 1973) they are not restricted
to neoplastic cells. Thus, autochthonous
PHA-transformed lymphoblasts (Weksler,
1973) and lymphoid cell lines (Han,
Moore and Sokal, 1971; Flier et al.,
1970) are capable of stimulating lympho-
cytes.
In an attempt to delineate the response
SI§
0-31***
0-76
0.42***
0 74
<0-001
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of AML remission lymphocytes to acute-
phase blasts, aspects of the response were
investigated in the present study. Since
all patients do not invariably respond to
acute-phase blasts, the present results
include results from those who did not
respond, as well as from those who did.
The 2 patients who responded in the
time-course experiments to autochthonous
blasts showed a peak of stimulation
between the second and third (48-72 h)
day of culture. Moreover, the response
to allogeneic blasts used for immuno-
therapy in one patient (JC) occurred at
72 h, and to allogeneic Raji cells in
another patient (AH) at the same time.
The timing of this response is earlier than
that observed in the allogeneic mixed
lymphocyte culture (MLC) (Bach, Solliday
and Stambuck, 1970; Thorsby, 1974)
but a shift in the peak MLC response to
an earlier day is known to result when
the donor of the responding lympho-
cytes had been pre-immunized in vivo
with allogeneic lymphocytes (Bondevik
and Thorsby, 1974a). The implication
of the early MLC response is that the
responding cells are a pre-immune clone
recognizing B:LA serologically defined
antigens (Bondevik and Thorsby, 1974b).
A possible explanation of the early
autochthonous response observed in the
present study is that a similar pre-immune
lymphocyte clone reacts in vitro to
leukaemia-associated antigens. Further
evidence in favour of this explanation
is provided by Gutterman et al. (1972),
who observed that patients were able
to respond to autochthonous solubilized
leukaemia blasts, though these extracts
failed to stimulate allogeneic normal
lymphocytes. Moreover, Char etal. (1973)
showed that autochthonous blast cell
membrane extracts induced skin reac-
tivity in AML patients more frequently
than allogeneic extracts. Lymphocyte
responses to acute-phase AML blasts do
not, in our opinion, represent non-
specific thymidine incorporation as sug-
gested by Schweitzer et al. (1973) in
their study of mixed culture of ALL
cells and remission lymphocytes. It is
clear from the results presented here
that the early peak response to autoch-
thonous blasts can be differentiated from
the steady rise in 3H-TdR incorporation
in the control cultures. A further point
of disagreement between our results and
those of Schweitzer et al. (1973) is that
ratios of blasts: lymphocytes as low
as 0-6: 1 resulted in significant lympho-
cyte stimulation. The fact that we
observed that an increase in the number
of blasts amplified the response in one
patient, but not in the other, indicates
that specific responsiveness is not pos-
sessed by all patients.
The antigens of autochthonous leuk-
aemic blasts causing lymphocyte stimula-
tion have never been identified, the
reason undoubtedly being the difficulty
in identifying the specificity of the clone
of responding lymphocytes. Although
an intact and viable cell may be necessary
to induce a lymphocyte response, there
are difficulties in using untreated stimulat-
ing blasts, firstly because spontaneous
DNA synthesis in the control cultures
may mask specific stimulation, and second-
ly because any allogeneic leucocytes in
the stimulating cell preparation may
induce a two-way MLC reaction, though
careful checking of the treatment of
patients before obtaining the autoch-
thonous blasts can often exclude this
difficulty. Nevertheless, x-irradiation or,
better still, mitomycin C treatment of
the blasts is the method of choice, though
in one case (JC) in this study, even heat-
treated blasts caused stimulation.
Although stimulation of lymphocytes
by autochthonous lymphoid cell lines
was thought to have been caused by
blastogenic (or mitogenic) factors (Flier et
al., 1970) others have failed to find
evidence of such factors (Han et al.,
1971; Birnbaum, Siskind and Weksler,
1972). No evidence could be found in
the present study that mitogenic factors
were released by acute-phase blasts when
tested on control cultures or mixed
cultures of blasts and lymphocytes. In-
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deed the response both to autochthonous
and allogeneic cells was in somie cases
suppressed in the presence of soluble
blast-cell-derived factors. The suppres-
sive effect of AML pre-treatment serum
on the PHA response of normal lympho-
cytes (Walker et al., 1973) may be caused
by such AML blast-derived suppressive
factors. There is no doubt that stimula-
tion of remission lymphocytes by acute-
phase leukaemic blasts is of a much
lower magnitude than that observed by
allogeneic cell lines. Interestingly, allo-
geneic AML blasts appear to have a
similar stimulatory capacity to auto-
chthonous blasts. The similarity between
the stimulatory capacity ofautochthonous
and allogeneic transformed cell lines
(Birnbaum et al., 1972) and acute-phase
mononucleosis cells (Junge, Hoekstra and
Deinhardt, 1971.) has led Steel et al.
(1973) to speculate that autochthonous
stimulation could be caused by virally
coded modifications of histocompatibility
antigens. Strong evidence that the virus
responsible may be Epstein-Barr (EB)
virus has been presented by Bausher and
Smith (1973), who suggested that the
response to autochthonous cell lines may
represent the recognition of EB antigens
by a pre-immune lymphocyte clone. The
T-cell-derived cell line MOLT-4 is one
of the few cell lines lacking EB nuclear
antigens (EBNA, Reedman and Klein,
1973; Svedmyr, Deinhardt and Klein,
1974) and is characterized by its lack
of stimulatory antigens when tested in
mixed culture with allogeneic lympho-
cytes (Han and Minowada, 1973). How-
ever, the stimulatory capacity of auto-
chthonous AML blasts cannot be ascribed
to EB antigens, since AML blasts lack
EBNA (Svedmyretal., 1974; Taylor, G. M.,
unpublished), though the possibility that
some other antigen is involved is suggested
by the finding of leukaemia-associated
nuclear antigen in AML blasts (Klein et
al., 1973).
Elution of AML blasts with glycine-
HCI failed to increase their stimulatory
capacity, and argues against the par-
ticipation of facto rs blocking surface
antigens, such as have been demonstrated
by Vanky et al. (1973) on a minority
of solid tumours. Indeed the presence
of membrane immunoglobulin on AML
blasts, which correlated with their ability
to stimulate remission lymphocytes (Gut-
terman et al., 1973b) could be regarded
as playing a crucial part, perhaps com-
plexed with antigen, in initiating the
autochthonous response.
We are indebted to the staff of the
Department of Clinical Haematology for
allowing us to study their patients, to
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